Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $19.8200 (0.66%) ($19.7500 - $20.1500) on Mon. Feb. 6, 2006. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.5% (three month average) | RSI | 29 | Latest Price | $19.8200(0.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) QQQ(7%) EEM(6%) IWM(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.25% in a week (0% probabilities). SHY(-4%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.25% (StdDev 6.5%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $19.4(2.16%) | 10 Day Moving Average | $19.4(2.16%) | 20 Day Moving Average | $19.75(0.35%) | To recent high | -11.6% | To recent low | 76.2% | Market Cap | $3.497b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |